Alexander M. Capron - Chair

Alexander Capron, LLB, holds the rank of university professor at the University of Southern California (USC), where he occupies the Scott H. Bice Chair in Healthcare Law, Policy and Ethics; teaches public health law, health policy, torts, and bioethics in the Gould School of Law and the Keck School of Medicine; serves as co-director of USC’s Pacific Center for Health Policy and Ethics; and leads the Research Ethics Program of the Southern California Clinical and Translational Science Institute. Professor Capron previously taught at Georgetown University, the University of Pennsylvania, and Yale University. From 2002 to 2006, he served as the first director of Ethics, Trade, Human Rights, and Health Law at the WHO in Geneva, and from 1979 to 1983 he was the executive director of the President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Professor Capron is a founding fellow of The Hastings Center, an elected member of the Institute of Medicine and of the American Law Institute, as well as a fellow of the American Association for the Advancement of Science. He has been president of the International Association of Bioethics and of the American Society of Law, Medicine and Ethics, and he currently serves as the secretary of PRIM&R’s Board of Directors. Professor Capron is a member of the 2012 AER Conference CCPC.

Susan Kornetsky, MPH - Vice Chair

Susan Z. Kornetsky, MPH, is the director of clinical research compliance at Boston Children’s Hospital. For the past 29 years, her responsibilities have included: Directing an IRB administrative office, educating principal investigators regarding IRB regulations, assisting investigators with protocol development, assuring institutional compliance with all federal and state regulations pertaining to human research, establishing appropriate policies and procedures, and overseeing a quality improvement program for human research protections. In May of 2010, she completed a medical ethics fellowship at Harvard Medical School. Ms. Kornetsky is a past appointed member of the SACHRP Subcommittee on Children, and currently serves on the SACHRP Subpart A Subcommittee. She is a past board member and site visitor for AAHRPP, as well as a former member of the IOM’s Committee on Clinical Research Involving Children. She currently serves on the Scientific and Research Advisory Committee for the Massachusetts Down Syndrome Congress. She has also served as a consultant for federal agencies. Ms. Kornetsky has been a member of PRIM&R’s Board of Directors since 2001, serving as vice chair from 2005 through 2007, and 2013, and chair of the Education Committee from 2002 through 2009. In 2003, Ms. Kornetsky received PRIM&R’s Distinguished Service Award. She lectures at many national meetings, in addition to PRIM&R’s conferences and educational programs, and is co-chair of PRIM&R’s 2012 AER Conference.

Susan S. Fish, PharmD, MPH - Secretary

Susan Fish, PharmD, MPH, is a professor of biostatistics and epidemiology at the Boston University School of Public Health. Dr. Fish received her Doctor of Pharmacy degree from the University of Minnesota and her Masters of Public Health from Boston University. She received a bachelor’s degree in pharmacy from Massachusetts College of Pharmacy and Allied Health Sciences and a bachelor’s degree in chemistry and education from the University of Massachusetts. Dr. Fish is the co-director of the masters in clinical research program at Boston University School of Medicine (BUSM). She previously held positions as director of human subjects protection and associate director of the Office of Clinical Research at Boston University Medical Center (BUMC), director of the BUMC IRB, and director of research participant safety at the General Clinical Research Center at BUSM. She has also served as director of regulatory affairs at CareStat, Inc. (a contract research organization), vice chair for research in the Department of Emergency Medicine at Boston City Hospital/Boston Medical Center, and associate professor of emergency medicine at BUSM. Prior to that, she was associate director of the Massachusetts Poison Control System and an associate professor at Massachusetts College of Pharmacy and Allied Health Sciences. On the national level, Dr. Fish is an active member of many organizations, including the Society for Academic Emergency Medicine and PRIM&R, where she serves on the Board of Directors. Dr. Fish is a member of the 2012 AER Conference CCPC and is co-chair of the Poster-Abstract Sub-Committee.

David A. Borasky, Jr., MPH, CIP - Treasurer

David A. Borasky, Jr., MPH, CIP works as the Deputy Director in the Office of Human Research Ethics at the University of North Carolina at Chapel Hill. He has over 14 years of experience managing institutional review boards (IRBs), as well as facilitating training activities on basic research ethics and IRB operations and function for research staff and their collaborators worldwide. He is a co-author of the award-winning Research Ethics Training Curriculum and the Research Ethics Training Curriculum for Community Representatives, which together have been used to train individuals in over 70 countries. He is a contributing author of Institutional Review Board: Management and Function (Amdur and Bankert, eds.). In addition, David has provided hands-on assistance to IRBs throughout North America, Africa and Asia, specializing in capacity building activities for IRBs in low-resource settings. He has served as a consultant for the Office of Human Research Protections, the US Department of Energy, the World Health Organization and numerous other institutions. David is proud to be a Certified IRB Professional^® and member of the Board of Directors for PRIM&R. He frequently lectures on the challenges of the review of research in developing country settings, and has published articles on research ethics training and international perspectives on informed consent.

A. Cornelius Baker

A. Cornelius Baker is a senior communications advisor at the Family Health International (FHI) 360 Center on AIDS and Community Health and the senior policy advisor for the National Black Gay Men’s Advocacy Coalition. Mr. Baker serves on the boards of PRIM&R, the Black AIDS Institute, Broadway Cares/Equity Fights AIDS, Us Helping Us, and the executive committee of the Forum for Collaborative Research on AIDS. In 2009, he was appointed as a member of the President’s Advisory Council on HIV/AIDS. Previously, he has served as the executive director of Whitman-Walker Clinic and executive director of the National Association of People with AIDS (NAPWA). Mr. Baker also worked as a confidential assistant to the assistant secretary for health at the U.S. Department of Health and Human Services in the National AIDS Program Office (NAPO). Mr. Baker has served on multiple panels and committees dedicated to the treatment and prevention of HIV, as well as to the health of the lesbian and gay community. Among many honors, he has received the Courage Award at the Washington AIDS Walk for outstanding leadership in living with HIV disease, the National Lesbian and Gay Health Association’s Diego Lopez Award for leadership in HIV advocacy, the American Foundation for AIDS Research Award of Courage for Community Building, and the National Association of People with AIDS’ Braveheart Award. He was honored by Planned Parenthood of Metropolitan Washington in 2004 for his support of women’s health and community leadership. He is a native of central New York and received his undergraduate degree at Eisenhower College/Rochester Institute of Technology.

Joseph J. Byrne, PhD

Joseph J. Byrne joined Tufts University in 1969, and held various positions until retirement in 1998, including University Associate Provost for Research, Assistant Professor of Family Medicine and Community Health, and Associate Dean for Medical and Governmental Affairs at the School of Medicine.  Dr. Byrne was appointed Associate Provost Emeritus and Assistant Professor Emeritus upon retirement. He also served, until retirement, as a member of the Operating Board of Tufts-New England Medical Center, a corporation providing common services to the Tufts Health Sciences Campus and the New England Medical Center, including the IRB, Lab Animal Medicine, Radiation and Biosafety services, and more..Dr. Byrne's continuing health-related activities include board membership in the Caritas Health Care System and the Biomedical Sciences Exchange Program). He currently serves as a Core Faculty Planner for the International Academy of Life Sciences, based in Potsdam, Germany, which is developing a new M.Sc. International Management in Life Sciences program. Dr. Byrne began his PRIM&R relationship as an original member of the Boston-based informal group in 1972, and then co-founding Director in 1974. He served as Treasurer and Executive Committee Member until 2001.  He has served as Board Director for 35 years. In 2005, he received PRIM&R’s Founders’ Award in recognition of his long service to the organization.

Leonard Glantz, JD

Leonard Glantz is a Professor of Health Law at the Boston University School of Public Health,  a Professor of Sociomedical Sciences and Community Medicine in the Medical School, and a Professor of Law in the Law School. Professor Glantz is the author of numerous books, articles, reports, and appellate briefs on medico-legal issues. He has spent much of his career examining issues related to the protection of human subjects. He is the author or editor of two books: Informed Consent to Human Experimentation with George Annas and Barbara Katz (1977) and Children as Research Subjects: Science, Ethics and Law, co-edited with Michael Grodin (1994).  He has been an IRB member for over 25 years. Current research interests include reproductive rights, rights of the terminally ill, the regulation of research with human subjects, children's rights, the constitutional limits  of public health regulation and the legal aspects of AIDS.

Cynthia A. Gómez, PhD

Cynthia A. Gómez is the founding director of Health Equity Institute at San Francisco State University where she leads efforts to enhance and integrate campus research, curricula, community service, and training programs that address health disparities and/or promote health equity in the United States. She previously served as co-director of the Center for AIDS Prevention Studies (CAPS) at the University of California at San Francisco, where she was also an associate professor in the Department of Medicine since 1991.  She received her master’s degree in counseling psychology from Harvard University and her PhD in Clinical Psychology from Boston University. Prior to her work with CAPS, Dr Gómez spent 12 years working in community health settings, including five years as director of a child and family mental health center in Boston.  Dr. Gómez is considered a pioneer in the areas of cultural determinants in sexual behaviors among Latinos, in the role of power dynamics in sexual risk among women, and in the development of HIV prevention interventions, including interventions for people living with HIV. Dr. Gómez is a nationally renowned speaker and an expert in the field of HIV prevention and sexual health.  She has served on several national committees, including the Center for Disease Control’s HIV and STD Advisory Council, National Institute on Drug Abuse’s National Hispanic Science Network, and the Substance Abuse and Mental Health Services Administration’s Advisory Committee on Women’s Services.  She is a member and past chair of the board of directors of the Guttmacher Institute. Dr Gómez was also an appointed member to the Presidential Advisory Council on HIV/AIDS under both WJ Clinton and GW Bush administrations.

Christine Grady, MSN, PhD

Tanise L. Jackson, DVM, DACLAM

Tanise L. Jackson is an assistant professor at Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences and the director of the Office of Animal Welfare and Research Integrity, Division of Research, in Tallahassee, FL. Dr. Jackson is responsible for direction of care and maintenance of laboratory animals at the Florida A&M University Animal Care Facility. Dr. Jackson also holds responsibility for Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Accreditation for the Animal Care Facilities at FAMU, February 2003. She is a member of American Association for Laboratory Animal Science and she sits on the Board of Trustees of AAALAC International, representing Association of Minority Health Professions Schools. Prior to joining the FAMU faculty in 1997, Dr. Jackson worked for 10 years as supervisory veterinary medical officer for the Food Safety and Inspection Service of the United States Department of Agriculture in its Atlanta, GA, Field Operations. Dr. Jackson's research interests include drug delivery for lung and breast cancer.

Moira Keane, MA, CIP

Moira Keane is the former Executive Director of the University of Minnesota,  Human Research Protection Program which includes the Institutional Review Board (IRB), and the Institutional Biosafety Committee (IBC). The HRPP oversees the research of all University of Minnesota campuses which encompasses review of basic science, clinical research, and social and behavioral sciences projects conducted by faculty, staff, and students. She is actively involved in subjects protections and served as Chair of the AAHRPP Council on Accreditation, as Vice Chair of the Council on Certified IRB Professionals (CCIP), and as a member of the Secretary’s Advisory Committee on Human Subjects Protection (SACHRP) Sub Part A Sub Committee.  

Robert J. Levine, MD

Robert J. Levine is Professor of Medicine and Lecturer in Pharmacology, Senior Fellow in the Interdisciplinary Center for Bioethics (of which he was Founding Co-Director) and Director of the Law, Policy and Ethics Core of the Center for Interdisciplinary Research on AIDS at Yale University. He is Fellow of The Hastings Center, the American College of Physicians and the American Association for the Advancement of Science; a member of the American Society for Clinical Investigation and American Society for Pharmacology and Experimental Therapeutics, past-President of the American Society of Law, Medicine & Ethics (two terms), and past-Chairman of the Connecticut Humanities Council. He was the Chair of the Institutional Review Board at Yale-New Haven Medical Center (1969 - 2000), Chief of the Section of Clinical Pharmacology at Yale, Chair of the Section on Medico-Legal Matters and R&D Administration of the American Society for Clinical Pharmacology and Therapeutics, Associate Editor of Biochemical Pharmacology and Editor of Clinical Research. Dr. Levine is the founding editor of IRB: A Review of Human Subjects Research (Editor 1979 – 2000 and currently Chair of the Editorial Board) and has served as consultant to several federal and international agencies involved in the development of policy for the protection of human subjects. He was, for example, Chair of the Council for International Organizations of Medical Sciences' Steering Committee for revision of its International Ethical Guidelines for Biomedical Research Involving Human Subjects (1993 and 2002 versions). He is the author of numerous publications including the book, Ethics and Regulation of Clinical Research. In the last 35 years, most of Dr. Levine's research, teaching and publications have been in the field of medical ethics with particular concentration on the ethics of research involving human subjects. Additionally, Dr. Levine was awarded the Outstanding Achievement Medal from the Office for Human Research Protection, US Department of Health and Human Services in 2004 for his role in the development of the Belmont Report; he received the Lifetime Award for Excellence in Human Research Protection from the Health Improvement Institute in 2004; he received PRIM&R’s Lifetime Achievement Award for Excellence in Research Ethics in 2005, the Distinguished Alumni Scholar Award from The George Washington University in 2008 and the Academy of Pharmaceutical Physicians and Investigators’ Special Recognition Award in 2009.

Christian E. Newcomer, VMD, MS, DACLAM

Christian E. Newcomer, VMD, MS, DACLAM is the executive director of AAALAC International and has participated in AAALAC’s review activities for the past 27 years. He is a 1977 graduate of the School of Veterinary Medicine at the University of Pennsylvania. Following a year in a large animal internship at Pennsylvania State University, he entered post-doctoral training in laboratory animal medicine at the University of Michigan (1978-1981) and subsequently became board certified as a Diplomate in American College of Laboratory Animal Medicine in 1982. Prior to his appointment at AAALAC International he held academic and leadership positions in laboratory animal medicine at the Massachusetts Institute of Technology (1981-1987), Tufts-New England Medical Center (1987-1994), University of North Carolina at Chapel Hill (1994-2001), the Veterinary Resources Program at the NIH (2001-2003), and Johns Hopkins University (2003-2008). He is a past president of ACLAM (1996) and of AALAS (2008), and a past vice president of the AAALAC International Council on Accreditation (1996-8). He was a member 2012 IACUC Conference Planning Committee and is co-chairing the 2013 PRIM&R IACUC Conference Planning Committee. He has frequently participated as a member of the IACUC Conference Faculty since 1989.

Judy Norsigian

Judy Norsigian, Executive Director and co-founder of Our Bodies Ourselves (formerly called the Boston Women's Health Book Collective), is a co-author of Our Bodies, Ourselves and Our Bodies, Ourselves for the New Century. She served on the board of the National Women's Health Network for over 14 years, served on two Institute of Medicine committees related to contraceptive research, served on several DSMBs for clinical trials, has been a member of the Technical Advisory Committee for CONRAD (the Contraceptive Research and Development Program) for more than 10 years, and has served on several planning committees for the Office of Research on Women's Health at NIH. She is also a member of the advisory board of the Council for Responsible Genetics.

P. Pearl O'Rourke, MD

P. Pearl O’Rourke is the Director of Human Research Affairs at Partners HealthCare Systems in Boston and an Associate Professor of Pediatrics at Harvard Medical School.  As the Director of Human Research Affairs, she is responsible for the systems that support the regulatory and ethical oversight of human research and the responsible conduct of research.  Dr. O’Rourke is the past chair of PRIM&R’s Board of Directors, and has been a speaker at a number of PRIM&R meetings, addressing topics such as privacy, human embryonic stem cells, and the reporting of serious adverse events.  She is also Chair of Partners Healthcare System’s newly formed ESCRO Committee. Dr. O’Rourke has worked as a pediatric critical care physician at Children's Hospital, Boston and at the Children's Hospital, University of Washington in Seattle where she was the Director of the Pediatric Intensive Care Unit.  Additionally, in Seattle, she served many years as a member of the IRB.  Dr. O’Rourke has also been involved in international medical care, serving in China and Indonesia with Project HOPE.  In 1995-1996, she did a Robert Wood Johnson Health Policy fellowship and worked for Senator Edward Kennedy (Democrat-MA) as a member of the Labor Committee Staff.  Following this fellowship, she became the Deputy Director of the Office of Science Policy in the Office of the Director at the NIH where she worked on issues such as privacy, gene therapy (transfer) embryonic stem cells, and genetic discrimination.

Harry Rozmiarek, DVM, PhD, DACLAM

Harry Rozmiarek was Professor Emeritus of Laboratory Animal Medicine at the University of Pennsylvania and Director of Laboratory Animal Medicine and Facilities at the Fox Chase Cancer Center. Dr. Rozmiarek joined the University of Pennsylvania in 1987 as professor of Laboratory Animal Medicine and director of University Laboratory Animal Resources. He also served as University Veterinarian and Associate Director of the Office of Regulatory Affairs and as director of International Development (USAID), was appointed by the National Research Council (ILAR) as the national member in 2004, represented the United States on the International Council for Laboratory Animal Science (ICLAS), and was elected to the ICLAS Governing Board in 2007. Dr. Rozmiarek’s contributions and leadership in laboratory animal medicine were recognized by his election as AALAS National president in 1983, president of the American Society of Laboratory Animal Practitioners in 1992, president of the American College of Laboratory Animal Medicine (ACLAM) in 1997, Chairman of the AAALAC International Board of Trustees in 2005, and numerous other positions of leadership in these and other organizations. He was awarded the AALAS Griffin Award in 1995 and the Charles River Prize of the American Veterinary Medical Association in 1996, was appointed a Fulbright Scholar and studied at the University of Cambridge for the 2002-2003 year, and received the Lifetime Achievement Award from the Pennsylvania Veterinary Medical Association in 2009. Dr. Rozmiarek is author of over 60 scientific publications and presentations and was co-recipient of the AALAS Research Award in 1980. He has been published extensively in the fields of immunology, toxicology, virology and infectious disease, and laboratory animal management and husbandry. He has been a member of the Editorial Committees for the Guide for the Care and Use of Laboratory Animals (1995) and the Institutional Animal Care and Use Committee Guidebook (1992 and 2002). He served on the Editorial Advisory Committee and Scientific Review Board for the AALAS Contemporary Topics Journal, as Editor Emeritus for the Shanghai Laboratory Animal Science Journal, and referee for numerous other scientific journals. Dr. Rozmiarek, a beloved member of PRIM&R’s Board of Directors since 1990, passed away in June of 2013.

Ada Sue Selwitz, MA

Ada Sue Selwitz is responsible for assisting the University of Kentucky in developing institutional policies pertaining to a variety of compliance issues such as protection of human subjects, scientific misconduct, humane care and use of animals, and data retention.  Since 1978, she has worked at the University of Kentucky Research Foundation in a variety of roles including Director of Sponsored Program Development.  Since 1999, Ms. Selwitz has been Director of the Office of Research Integrity.  She has an Adjunct Associate Professor appointment in the Department of Behavioral Sciences in the College of Medicine.  Ms. Selwitz has co-authored publications and given over 100 national/state presentations.  Ms Selwitz has been involved in nine extramurally funded research projects funded by the National Institutes of Health (NIH), the Scientist Center on Animal Welfare, and the National Science Foundation.  She has been the recipient of several national awards such as Society of Research Administrators Excellence Award, Applied Research Ethics National Association Distinguished Service Award, ARENA Appreciation Award and National Council of University Administrators Outstanding Achievement in Research Administration Award.  Ms. Selwitz has served a leadership role within the state and nation through her participation in several national and federally sponsored education and policy development initiatives.  She served on the Department of Health and Human Services Advisory group on the Public Health Service Responsible Conduct of Research policy, the NIH Regulatory Burden Committee and chaired the NIH Regulatory Burden Human Research Protection Subcommittee.  Ms. Selwitz was co-faculty in the Investigator 101 CD-Rom which has been distributed by the Office of Human Research Protections to all institutions with assurances.  She co-founded PRIM&R’s IRB 101 program.

Barbara Stanley, PhD

Barbara Stanley, PhD, is a clinical psychologist and Research Scientist in the Department of Neuroscience at the New York State Psychiatric Institute and Professor in the Department of Psychiatry at Columbia University. She has conducted research and published more than 70 articles on clinical factors, neurobiology, and treatment of suicidal behavior, self injury, borderline personality disorder, and depression. She is the recipient of more than twenty years of continual funding from the National Institute of Mental Health (NIMH) and has also received grants from several private foundations. Dr. Stanley is the President of the American Foundation for Suicide Prevention Metropolitan New York Chapter and serves on its Scientific Advisory Board. She also serves on the board of the Personality Disorders Foundation and TARA Association for Personality Disorders. She has served on several Institutional Review Boards and has been a consultant for the NIH Office of Protection from Research Risks. Dr. Stanley has also served as a consultant to the NIMH in developing guidelines for investigators who consider including suicidal patients in treatment trials. She is currently the Director of the NIMH Developing Center on Interventions for the Prevention of Suicide, and the Principal Investigator on two NIMH-funded grants, one of which involves psychosocial medication treatment trial for actively suicidal and self-injuring individuals, and the other examines the neurobiological correlates and clinical factors that distinguish suicide attempters and non-attempters, as well as the state and trait predictors of suicide attempts.

Walter L. Straus, MD, MPH

Walter L. Straus is the Global Director for Scientific Affairs - Vaccines at Merck Research Laboratories, Merck & Co, Inc., where he leads a team that conducts research in vaccine-preventable and other infectious diseases, as well as oncology. The work spans early discovery through post-licensure assessments. As a result, he has involvement in issues ranging from molecular epidemiology, to development of patient-reported outcome measures for use in clinical trials, through to assessment of the safety and effectiveness of marketed products. While much of his work is done in support of clinical research, his group is also involved in basic research. Additionally, since so much of the burden of vaccine preventable diseases falls on developing countries, Dr. Straus’ team is also involved in epidemiologic assessment of disease in areas of the world normally outside of sphere that has historically characterized pharmaceutical development. This activity has led to his active involvement in internal discussions about proper research ethical considerations for research in developing countries. Dr. Straus is a former Epidemic Intelligence Service Officer at the Centers for Disease Control and Prevention, and has served as a consultant to the World Health Organization and other non-governmental organizations. His primary medical ethics focus is upon ensuring appropriate research protection for vaccine research in developing countries. His team is active in scientific presentations and publications. He serves as a Technical Consultant to the AHRQ Center for Education and Research on Therapeutics at the University of Alabama, and holds an adjunct appointment with the Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania.

Jeremy Sugarman, MD, MPH, MA

Jeremy Sugarman is the Harvey M. Meyerhoff Professor of Bioethics and Medicine, professor of medicine, professor of health policy and management, and deputy director for medicine of the Berman Institute of Bioethics at the Johns Hopkins University in Baltimore, MD. Dr. Sugarman conducts both theoretical and empirical research in medical ethics. His work concentrates on informed consent, research ethics, and the ethical issues associated with emerging technologies as well as global health. He is the author of nearly 200 publications in peer-reviewed journals. He has also edited or co-edited four books (Beyond Consent: Seeking Justice in Research; Ethics of Research with Human Subjects: Selected Policies and Resources; Ethics in Primary Care; and Methods in Medical Ethics). Dr. Sugarman is an associate editor of Clinical Trials, a contributing editor for IRB, and is on the editorial boards of Accountability in Research and Theoretical Medicine and Bioethics. Dr. Sugarman serves on the Scientific and Research Advisory Board for the Canadian Blood Service and is a member of the Maryland Stem Cell Research Commission. He is currently chair for the Ethics Working Group of the HIV Prevention Trials Network, the ethics officer for the Resuscitation Outcomes Consortium, and Co-Chair of the Johns Hopkins' Institutional Stem Cell Research Oversight Committee. Dr Sugarman is a member of the American Society of Clinical Investigation and a fellow of the American Association for the Advancement of Science, the American College of Physicians, and the Hastings Center. Recently Dr. Sugarman was honored with election to the Institute of Medicine, one of the highest honors in the field of health and medicine.

Hugh Tilson, MD, MPH, DrPH

Hugh Tilson, MD, DrPH, is a practicing epidemiologist and outcomes researcher, whose career in public health and preventive medicine spans 40 years.  Upon his retirement from GlaxoWellcome in 1996, Dr. Tilson joined the clinical faculty of University of North Carolina (UNC) School of Public Health in Chapel Hill.  He is Adjunct Professor of Social Medicine at UNC and an Adjunct Professor of Medicine at Duke University.  He is an advisor to government and industry in health outcomes, drug safety, and evidence based health policy, including, most recently, public health preparedness.  He was Founding Co-President of the International Society for Pharmacoepidemiology and a Founding Member of the International Society for Pharmacoeconomics and Outcomes Research, and of the Academy of Pharmaceutical Physicians and Investigators (APPI), and has served as chair of the Committees for Bylaws and Policies for all three.  Dr. Tilson is Past President of the American College of Preventive Medicine, where he continues to be active in policy affairs and has recently been appointed a member of the Committee on Ethics.  Dr. Tilson serves as senior advisor and epidemiologist for the international Antiretrovirals in Pregnancy Registry and Bupropion in Pregnancy Registry.  He was a member of the recently adjourned Clinical Research Roundtable and served as a consultant to Institute of Medicine’s landmark study, “The Future of Drug Safety,” released in 2006. Recipient of many prestigious appoints and awards, he was presented the 2006 Ward Hampton Frost Award. 

Joan Rachlin, JD, MPH

Joan Rachlin, JD, MPH, is the Executive Director of Public Responsibility in Medicine and Research (PRIM&R), an organization dedicated to educating, informing, and providing a forum for those involved in the ethical, legal, and policy dimensions of research. Ms. Rachlin holds a JD from the Suffolk University School of Law and an MPH from the Harvard School of Public Health. In addition to her work with PRIM&R, Ms. Rachlin practiced law for many years, concentrating in the areas of health law and civil rights.  She has taught at several Boston area colleges and lectured extensively on issues relating to research ethics and women’s health.  Ms. Rachlin is a contributor to the well-known book, Our Bodies, Ourselves, and serves on the Advisory Committee of the Boston Women’s Health Book Collective.

Questions?
Please contact us via email or telephone at 617.423.4112, ext. 0. Thank you!